Mie, Japan

Narimasa Iwamoto



Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Narimasa Iwamoto: Innovator in Microfluidic and Nucleic Acid Amplification Technologies

Introduction

Narimasa Iwamoto is a distinguished inventor based in Mie, Japan. He has made significant contributions to the fields of microfluidics and nucleic acid amplification, holding a total of three patents. His innovative work has the potential to advance various applications in biotechnology and medical diagnostics.

Latest Patents

Iwamoto's latest patents include a microfluidic device designed to reduce fluctuations in the solution feeding rate of a reaction solution. This device features a flow path that alternates between two temperature regions, allowing for precise control over the reaction conditions. Another notable patent is for a nucleic acid amplification device that utilizes capillary force to transport reaction solutions containing target nucleic acids. This device is equipped with multiple temperature zones to facilitate efficient amplification of nucleic acids.

Career Highlights

Throughout his career, Narimasa Iwamoto has worked with prominent companies, including Panasonic Intellectual Property Management Co., Ltd. and Panasonic Corporation. His experience in these organizations has allowed him to develop and refine his innovative technologies, contributing to the advancement of the industry.

Collaborations

Iwamoto has collaborated with notable colleagues such as Hiroaki Tachibana and Tsutomu Ichihara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in their respective fields.

Conclusion

Narimasa Iwamoto's contributions to microfluidic and nucleic acid amplification technologies highlight his role as a leading inventor in Japan. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…